In THA or TKA, risk for symptomatic VTE was higher with aspirin vs. enoxaparin at 90 d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36469926.
- Also identified by DOI 10.7326/J22-0096.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CRISTAL Study Group; Sidhu VS, Kelly TL, Pratt N, et al. <b>Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial.</b> JAMA. 2022;328:719-27. 35997730.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Venous Thromboembolism